Clinical Impact of Double Protease Inhibitor Boosting with Lopinavir/Ritonavir and Amprenavir as Part of Salvage Antiretroviral Therapy
暂无分享,去创建一个
C. Kovacs | M. Loutfy | J. Raboud | S. Walmsley | E. Phillips | A. Rachlis | A. Tseng | K. Gough | C. Thompson | G. Rubin | Z. Abdurrahman